Literature DB >> 699400

Focal segmental glomerulosclerosis with rapid decline in renal function ("malignant FSGS").

C B Brown, J S Cameron, D R Turner, C Chantler, C S Ogg, D G Williams, M Bewick.   

Abstract

We describe 11 patients whose renal biopsies showed minimal changes with focal segmental glomerulosclerosis. These patients, in contrast to the majority of patients with similar renal histology, went into renal failure within 2 1/2 years of clinical onset. All were young, severely nephrotic, most hypertensive, with microscopic hematuria, non-selective proteinuria and extreme hypercholesterolemia. Treatment with corticosteroids and cytotoxic drugs was without effect in any patient. Despite rapid decline in renal function, profuse proteinuria and a nephrotic syndrome persisted into terminal uremia and continued even after dialysis had begun. Seven patients were given nine allografts; four grafts failed because of immediate vascular complications, and a persistant nephrotic syndrome was evident in two of the five surviving grafts. This did not, however, lead to graft failure. Two patients died on dialysis because of myocardial problems. These patients with rapid decline in renal function constitute a distinct clinical subgroup amongst those with focal and segmental glomerulosclerosis; it is possible that they have a different primarily vascular pathogenesis in contrast to other patients with similar renal biopsy appearances.

Entities:  

Mesh:

Year:  1978        PMID: 699400

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  13 in total

1.  Long-term efficacy of low-density lipoprotein apheresis for focal and segmental glomerulosclerosis.

Authors:  Yukihiko Kawasaki; Sigeo Suzuki; Ayumi Matsumoto; Kei Takano; Kazuhide Suyama; Koichi Hashimoto; Junzo Suzuki; Hitoshi Suzuki; Mitsuaki Hosoya
Journal:  Pediatr Nephrol       Date:  2007-02-03       Impact factor: 3.714

2.  Focal glomerulosclerosis in children: an Argentinian experience.

Authors:  A Tufro-McReddie; E Alvarez; E Arrizurieta; H Repetto
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

3.  Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A.

Authors:  A Meyrier; P Simon; G Perret; M C Condamin-Meyrier
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-22

4.  An unusual interpodocyte cell junction and its appearance in a transplant graft kidney.

Authors:  D J Harrison; D Jenkins; J Dick
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

5.  Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.

Authors:  P Tarshish; J N Tobin; J Bernstein; C M Edelmann
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

6.  [Current problems of glomerulonephritis (author's transl)].

Authors:  W Thoenes
Journal:  Klin Wochenschr       Date:  1979-08-15

7.  Cyclosporin A in refractory idiopathic nephrotic syndrome: 5 years clinical experience.

Authors:  M P Delaney; D C Dukes; M E Edmunds
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

8.  Focal sclerosing glomerulopathy. Risk factors of progression and optimal mode of treatment.

Authors:  P C Chan; K W Chan; I K Cheng; M K Chan
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

9.  Focal segmental glomerulosclerosis in children: comparison of nonedematous and edematous patients.

Authors:  S Roy; F B Stapleton
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

10.  Efficacy of steroid pulse, plasmapheresis, and mizoribine in a patient with focal segmental glomerulosclerosis.

Authors:  Tomoko Imaizumi; Yukihiko Kawasaki; Hiromi Matsuura; Ayumi Matsumoto; Kei Takano; Kazuhide Suyama; Koichi Hashimoto; Hitoshi Suzuki; Mitsuaki Hosoya
Journal:  Pediatr Nephrol       Date:  2007-03-09       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.